APPLICATION OF NEW METHODOLOGY TO ALLOW COMPARISON OF DURATION OF RESPONSE AND DURATION OF CLINICAL BENEFIT BETWEEN FULVESTRANT TREATMENT GROUPS IN THE CONFIRM TRIAL

被引：0
|
作者：
Garnett, Sally [1 ]
Martin, Miguel [2 ]
Jerusalem, Guy [3 ]
Petruzelka, Lubos [4 ]
Torres, Roberto [5 ]
Bondarenko, Igor N. [6 ]
Khasanov, Rustem [7 ]
Verhoeven, Didier [8 ]
Pedrini, Jose L. [9 ]
Smirnova, Iya [10 ]
Lichinitser, Mikhail R. [11 ]
Pendergrass, Kelly [12 ]
Lindemann, Justin P. O. [1 ]
Di Leo, Angelo [13 ]
机构：
[1] AstraZeneca, Macclesfield, Cheshire, England
[2] Hosp Univ Gregorio Maranon, Madrid, Spain
[3] CHU Sart Tilman, B-4000 Liege, Belgium
[4] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[5] Inst Nacl Canc, Santiago, Chile
[6] Dnipropetrovsk Municipal Clin Hosp, Dnepropetrovsk, Ukraine
[7] Republican Clin Oncol Ctr, Kazan, Russia
[8] AZ Klina, Brasschaat, Belgium
[9] Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil
[10] Med Radiol Sci Ctr, Obninsk, Russia
[11] Russian Canc Res Ctr, Moscow, Russia
[12] Kansas City Canc Ctr, Kansas City, KS USA
[13] Hosp Prato, Prato, Italy
来源：
BREAST | 2011年 / 20卷
关键词：
D O I：
10.1016/j.breast.2011.08.098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 22 条
  • [1] Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology
    Sally Anne Garnett
    Miguel Martin
    Guy Jerusalem
    Lubos Petruzelka
    Roberto Torres
    Igor N. Bondarenko
    Rustem Khasanov
    Didier Verhoeven
    José L. Pedrini
    Iva Smirnova
    Mikhail R. Lichinitser
    Kelly Pendergrass
    Justin P. O. Lindemann
    Angelo Di Leo
    Breast Cancer Research and Treatment, 2013, 138 : 149 - 155
  • [2] Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology
    Garnett, Sally Anne
    Martin, Miguel
    Jerusalem, Guy
    Petruzelka, Lubos
    Torres, Roberto
    Bondarenko, Igor N.
    Khasanov, Rustem
    Verhoeven, Didier
    Pedrini, Jose L.
    Smirnova, Iva
    Lichinitser, Mikhail R.
    Pendergrass, Kelly
    Lindemann, Justin P. O.
    Di Leo, Angelo
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (01) : 149 - 155
  • [3] EFFICACY OF FULVESTRANT ACCORDING TO DURATION AND TYPE OF ADJUVANT ENDOCRINE TREATMENT, IN METASTATIC BREAST CANCER PATIENTS ENROLLED IN THE CONFIRM TRIAL
    Malorni, L.
    Biagioni, C.
    Thirlwell, J.
    Guarducci, C.
    Bonechi, M.
    Rukazenkov, Y.
    Jerusalem, G.
    Martin, M.
    di Leo, A.
    Migliaccio, I.
    ANNALS OF ONCOLOGY, 2014, 25 : 11 - 11
  • [4] Influence of treatment duration on the efficacy of at-home bleaching with daytime application: a randomized clinical trial
    Iria L. Darriba
    Paloma Cabirta Melón
    Ana García Sartal
    Ignacio Ríos Sousa
    Víctor Alonso de la Peña
    Clinical Oral Investigations, 2019, 23 : 3229 - 3237
  • [5] Influence of treatment duration on the efficacy of at-home bleaching with daytime application: a randomized clinical trial
    Darriba, Iria L.
    Cabirta Melon, Paloma
    Garcia Sartal, Ana
    Rios Sousa, Ignacio
    Alonso de la Pena, Victor
    CLINICAL ORAL INVESTIGATIONS, 2019, 23 (08) : 3229 - 3237
  • [6] Relationship between Canagliflozin Treatment Response and Duration of Diabetes: The Association of British Clinical Diabetologists (ABCD) Nationwide Canagliflozin Audit
    Ryder, Robert E. J.
    Phillips, Suzanne M.
    Evans, Alison
    Sennik, Devesh K.
    Rohilla, Anurita
    Bickerton, Alex
    Thong, Ken
    Yadagiri, Mahender
    Cull, Melissa L.
    Wyres, Melanie C.
    Winocour, Peter
    Darzy, Ken H.
    Strzelecka, Anna
    Gohil, Shailesh G.
    Gallagher, Alison
    Gallen, Ian W.
    DIABETES, 2019, 68
  • [7] Dose-Response Relationship Between Exercise Duration and Enhanced Function and Cognition in Acutely Hospitalized Older Adults: A Secondary Analysis of a Randomized Clinical Trial
    de Asteasu, Mikel L. Saez
    Martinez-Velilla, Nicolas
    Zambom-Ferraresi, Fabricio
    Galbete, Arkaitz
    Ramirez-Velez, Robinson
    Cadore, Eduardo L.
    Abizanda, Pedro
    Gomez-Pavon, Javier
    Izquierdo, Mikel
    INNOVATION IN AGING, 2024, 8 (06)
  • [8] Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial
    Singer, A.
    Schmidt, M.
    Hauke, W.
    Stade, K.
    PHYTOMEDICINE, 2011, 18 (8-9) : 739 - 742
  • [9] New international criteria for evaluating solid tumor response to treatment - Clinical trial groups, regulatory agencies trying to standardize, simplify work of clinical investigators
    不详
    BIOTECHNOLOGY LAW REPORT, 1999, 18 (04) : 334 - 335
  • [10] A Randomized Clinical Trial Comparison Between Pivotal Response Treatment (PRT) and Structured Applied Behavior Analysis (ABA) Intervention for Children with Autism
    Fereshteh Mohammadzaheri
    Lynn Kern Koegel
    Mohammad Rezaee
    Seyed Majid Rafiee
    Journal of Autism and Developmental Disorders, 2014, 44 : 2769 - 2777
123